Human menopausal gonadotrophin in a pre-filled injection pen is non-inferior to the US-approved powder formulation

Craig Witz, Eric D. Foster, Sarah A. Grover, Patrick W. Heiser

Open source

DOI
10.1016/j.rbmo.2026.105743
Published
2026-06
Container
Reproductive BioMedicine Online
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rbmo.2026.105743,
  title = {Human menopausal gonadotrophin in a pre-filled injection pen is non-inferior to the US-approved powder formulation},
  author = {Craig Witz and Eric D. Foster and Sarah A. Grover and Patrick W. Heiser},
  year = {2026},
  journal = {Reproductive BioMedicine Online},
  doi = {10.1016/j.rbmo.2026.105743},
  url = {https://doi.org/10.1016/j.rbmo.2026.105743}
}

RIS

TY  - JOUR
TI  - Human menopausal gonadotrophin in a pre-filled injection pen is non-inferior to the US-approved powder formulation
AU  - Craig Witz
AU  - Eric D. Foster
AU  - Sarah A. Grover
AU  - Patrick W. Heiser
PY  - 2026
JO  - Reproductive BioMedicine Online
DO  - 10.1016/j.rbmo.2026.105743
UR  - https://doi.org/10.1016/j.rbmo.2026.105743
ER  - 

APA

Witz, C., Foster, E. D., Grover, S. A., & Heiser, P. W. (2026). Human menopausal gonadotrophin in a pre-filled injection pen is non-inferior to the US-approved powder formulation. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105743

Source records